One-liner: “Biomonadic develops AI-based solutions for optimizing bioprocesses in the biotechnology sector, focusing on gene therapy and longevity therapies.”
Company slogan: We are creating a next generation AI platform to optimize cell and gene therapy manufacturing
Positioning: Biomonadic positions itself as a pioneer in optimizing bioprocesses for gene therapy and longevity therapies through advanced AI techniques.
Description: “Biomonadic is creating a next generation AI platform to optimize cell and gene therapy manufacturing, with the goal of democratizing these therapies for all.”
Employees: 5
Website: Visit websiteHeadquarters: –
Ownership: Privately Held
Founded: 2023
Company type: AI company
Use cases: “gene therapy process optimization, bioprocess optimization, manufacturing protocols customization”
Pricing: –
Client sector: biotechnology
Business model: subscription
Products: “AI-based data platform for bioprocess optimization, real-time data integration tools, customized manufacturing protocol solutions”
Is API available: no
Website title: Enterprise Generative AI
Website description: “Biomonadic is a next generation AI and IoT manufacturing platform to empower cell and gene therapy scaling with AI, sensorization, and realtime protocol automation to optimize quality, growth, and yield to reduce costs and improve therapeutic outcomes, striving to democratize these therapies for all”
Linkedin: https://www.linkedin.com/company/biomonadic
Youtube: –
Instagram: –
Facebook: –
Twitter: –
Crunchbase: –
Email: biomonadic@gmail.com